Redefining Medicine
Our mission is to revolutionise the way the world approaches healthcare.
Scroll Down
About Us
The Company
Breathe Life Sciences (BLS) is an Australian life sciences, pharmaceutical and consumer health products company, a wholly owned subsidiary of Bioxyne Limited whose shares are listed on the Australian Stock Exchange (BXN.ASX, PR8.F).
BLS is a GMP licensed pharmaceutical manufacturer of prescription medicines and active pharmaceutical ingredients (API) operating in Australia, the United Kingdom, Germany and Europe.
The Company specialises in the manufacture and supply of medicines for patients with unmet clinical needs.
BLS is currently licensed to manufacture and supply cannabis, MDMA 3,4-methylenedioxymethamphetamine, and Psilocybin.
BLS pharmaceutical operations span Australia, UK, Germany and other EU markets. The Company also manufactures and supplies consumer health products in the UK, Europe, and Japan both wholesale and direct to consumer
BLS is the owner of Dr Watson®, registered in the UK, Europe, Japan, Australia, and New Zealand.
Our Purpose
Redefining Medicine
We specialise in manufacturing investigational medicines derived from Cannabis, MDMA, and Psilocybin.
The prescription medicines we make are supplied to patients via special access schemes and authorized prescribers, dispensed by pharmacies in Australia, UK, Germany and other markets.
For a Healthier Tomorrow
A significant percentage of patients do not respond adequately to existing treatment options. For example, around 30% of patients suffering from depression are ”treatment resistant.” The medicines we manufacture give alternative treatment options for millions of patients with unmet clinical needs.
API and Starting Materials
+BLS is a licensed sponsor, importer, exporter, and wholesaler of Schedule 3, 4, and 8 controlled substances. We work with GACP/GMP cultivators and manufacturers of APIs and starting materials in 5 continents and have been active in Australia since 2020. We are a trusted supplier to cultivators, manufacturers, clinics and pharmacy.
White Label Manufacturing
+Whatever your needs, we can help you in finding the right solution. We offer compliant lab and manufacturing services to 3rd party clients & brands in Australia, UK, and EU. We are the market leader in terms of manufacturing scope for alternative medicines with a wide range of final dose forms and low MOQs
Distribution and Pharmacy
+BLS provides B2B wholesale services including import, export, vault storage, and distribution. Our services extend to nationwide distribution, fully integrated with pharmacies and clinics across Australia and the UK. The BLS platform is built to support our clients’ growth.
Key Impact Areas
The Company’s pharmaceutical activities are spearheaded in Australia, where wholly owned subsidiary BLS Wholesalers is licensed to import, export, wholesale, and manufacture Schedule 3,4 and 8 medicines including cannabis, MDMA, and Psilocybin. Our manufacturing facility in Brisbane is TGA GMP licensed for final dose form medicines and active pharmaceutical ingredients. We are developing similar manufacturing capabilities in the UK and Europe to better serve our growing client base in these key markets.
White Label Manufacturing
BLS is the trusted manufacturer for over 300 medicine brands in Australia.
Our Australian manufacturing facility can produce over 8 million finished medicine products per year, for supply into the Australian, UK, and European markets.
Get in Touch
Fill out the form below with your details, and a member of our team will get in touch with you as soon as possible to provide all the information and assistance you may need.